Jonathan Mow
Signal active
Chief Executive Officer
Contact Information
Social
Primary Organization
PhaseBio Pharmaceuticals
Founded
2002
Employees
51-100
Industry
Biotechnology, Pharmaceutical, Medical, Medical Device
Bio
Jonathan has more than 20 years experience in business development, marketing and commercial operations.
Prior to PhaseBio he served as Vice President, Business Development for Amylin Pharmaceuticals from 2007 until its sale to Bristol-Myers Squibb in 2012. Mr. Mow was Co-founder, Vice President, Commercial and Business Development, and Secretary of Corus Pharma, Inc. until their acquisition by Gilead Sciences in 2006.
He also led the Business Development efforts for PathoGenesis Corporation, culminating with the company’s acquisition by Chiron Corporation in 2000.
Prior to those roles, he held positions in marketing at Bristol Myers-Squibb, Wyeth/Lederle International and sales and marketing research at Syntex Laboratories.
Location
San Diego, California, United States, North America
Jobs history
0
N/A
Educations
1
N/A
Profile Resume
Jonathan Mow is the Chief Executive Officer at PhaseBio Pharmaceuticals, based in United States, North America. With a background in Biotechnology, Jonathan Mow has a rich history of leadership and innovation. Explore their detailed professional journey, key connections, and contributions to the industry on our platform.
Recommendation from your interest
N/A
Products and Innovations
0
There is no product and inovations for this profile.
Achievements
0
There is no Achievements for this profile.
Publications
0
There is no publication for this profile.
Recent Activity
There is no recent news or activity for this profile.